This Biotech Startup Is Out To Change How Drugs Are Prescribed

Olaris, founded in 2014 by Liz O’Day, is using “biomarkers of response” to determine the best possible course of drugs to treat patients most effectively. O’Day has a PhD from Harvard in biological and biomedical sciences.